Advanced Biomed Inc. Common Stock (ADVB) vs Jasper Therapeutics, Inc. (JSPR)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and Jasper Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.64HealthcareDelayed quote: Oct 6, 2026, 9:59 AM EDT
JSPR
Jasper Therapeutics, Inc.
$0.59HealthcareDelayed quote: Oct 6, 2026, 9:59 AM EDT
Total return — ADVB vs JSPR
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)JSPR -89.1% (-67.0%/yr)JSPR compounded faster over this window
ADVB JSPR
ADVB vs JSPR: by the numbers
- •JSPR is the larger company ($10M vs $9M market cap).
Metrics side by side
Valuation
| Metric | ADVB | JSPR |
|---|---|---|
| P/B ratio | 1.00 | 6.76 |
Profitability
| Metric | ADVB | JSPR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -7.36% | -2248.48% |
| ROIC | -11.06% | -1394.09% |
Growth (annualized)
| Metric | ADVB | JSPR |
|---|---|---|
| Total return CAGR (5Y) | N/A | -62.51% |
Go deeper
Dig into the metrics
Advanced Biomed Inc. Common Stock ROEJasper Therapeutics ROEAdvanced Biomed Inc. Common Stock operating marginJasper Therapeutics operating marginAdvanced Biomed Inc. Common Stock revenue growthJasper Therapeutics revenue growthAdvanced Biomed Inc. Common Stock free cash flowJasper Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.